Pharmabiz

MindRank doses first patient in phase III clinical trial of AI-designed oral GLP-1 receptor agonist, MDR-001

MindRank doses first patient in phase III clinical trial of AI-designed oral GLP-1 receptor agonist, MDR-001: Shanghai Saturday, February 28, 2026, 18:00 Hrs [IST] MindRank, a cli ...
Pharmabiz

Core Solutions introduces DSP Assist mobile app for compliant IDD service delivery

Core Solutions introduces DSP Assist mobile app for compliant IDD service delivery: King of Prussia, Pennsylvania Saturday, February 28, 2026, 17:00 Hrs [IST] Core Solutions (Core ...
Pharmabiz

Intelligent Bio Solutions ships Intelligent Fingerprinting Drug Screening Readers with Syrma Johari MedTech

Intelligent Bio Solutions ships Intelligent Fingerprinting Drug Screening Readers with Syrma Johari MedTech: New York Saturday, February 28, 2026, 16:00 Hrs [IST] Intelligent Bio ...
Pharmabiz

YD Bio partners with YC Biotech to establish Taiwan-US dual-core regulatory platform

YD Bio partners with YC Biotech to establish Taiwan-US dual-core regulatory platform: Taipei, Taiwan Saturday, February 28, 2026, 15:00 Hrs [IST] YD Bio Limited, a biotechnology c ...
Pharmabiz

CollPlant Biotechnologies’ photocurable dermal filler technology receives Korean Patent

CollPlant Biotechnologies’ photocurable dermal filler technology receives Korean Patent: Rehovot, Israel Saturday, February 28, 2026, 14:00 Hrs [IST] CollPlant Biotechnologies, ...